1.6394
price down icon57.59%   -2.1806
 
loading
Schlusskurs vom Vortag:
$3.82
Offen:
$1.79
24-Stunden-Volumen:
13.68M
Relative Volume:
69.22
Marktkapitalisierung:
$3.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.192
EPS:
-8.54
Netto-Cashflow:
$-8.25M
1W Leistung:
-55.12%
1M Leistung:
-55.00%
6M Leistung:
-85.38%
1J Leistung:
-94.91%
1-Tages-Spanne:
Value
$1.55
$1.80
1-Wochen-Bereich:
Value
$1.55
$4.19
52-Wochen-Spanne:
Value
$1.55
$75.60

Oragenics Inc Stock (OGEN) Company Profile

Name
Firmenname
Oragenics Inc
Name
Telefon
813-286-7900
Name
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Name
Mitarbeiter
6
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
OGEN's Discussions on Twitter

Vergleichen Sie OGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OGEN
Oragenics Inc
1.63 3.23M 0 -20.26M -8.25M -8.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.25 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.21 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.42 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.31 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.33 28.51B 3.81B -644.79M -669.77M -6.24

Oragenics Inc Aktie (OGEN) Neueste Nachrichten

pulisher
Jun 18, 2025

Major Shareholder Odyssey Health Sells Oragenics Stock! - TipRanks

Jun 18, 2025
pulisher
Jun 11, 2025

Future of Oral Probiotic Supplements | Innovations in Oral - openPR.com

Jun 11, 2025
pulisher
Jun 11, 2025

Oragenics Inc. to Showcase Concussion Treatment Candidate at Major 2025 Conferences - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention and At - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics, Inc. to Present ONP-002 at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Nasdaq

Jun 10, 2025
pulisher
Jun 10, 2025

GlobeNewswire by Notified - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium | OGEN Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - The Manila Times

Jun 10, 2025
pulisher
Jun 10, 2025

Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews

Jun 10, 2025
pulisher
Jun 10, 2025

Oragenics to Present at 2025 BIO International Convention - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

Top stock gains: US stocks posting the highest gains today - Yahoo

Jun 10, 2025
pulisher
Jun 06, 2025

Rocket Lab Corporation (RKLB): A Bull Case Theory - Yahoo

Jun 06, 2025
pulisher
Jun 06, 2025

Upstart Holdings, Inc. (UPST): A Bull Case Theory - Yahoo

Jun 06, 2025
pulisher
Jun 05, 2025

Vireo Growth Inc. Announces Closing of Proper Brands Acquisition in Missouri - Yahoo

Jun 05, 2025
pulisher
Jun 05, 2025

Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea - Yahoo

Jun 05, 2025
pulisher
Jun 04, 2025

Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews

Jun 04, 2025
pulisher
Jun 04, 2025

Top Premarket Decliners - MarketScreener

Jun 04, 2025
pulisher
Jun 03, 2025

Oragenics (OGEN) Resumes Trading: Key Insights for Investors | O - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Oragenics (OGEN) Trading Paused Due to High Volatility | OGEN St - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Oragenics (OGEN) Resumes Trading: Key Insights for Investors | OGEN Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

ABB acquires Bel Products Inc. to expand enclosures portfolio in North America - Yahoo

Jun 02, 2025
pulisher
Jun 02, 2025

Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews

Jun 02, 2025
pulisher
Jun 02, 2025

Oral Probiotics Supplements Gain Popularity in Digestive - openPR.com

Jun 02, 2025
pulisher
May 31, 2025

OGEN stock touches 52-week low at $0.12 amid sharp annual decline By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

OGEN stock touches 52-week low at $0.12 amid sharp annual decline - Investing.com Australia

May 30, 2025
pulisher
May 29, 2025

Oragenics announces reverse stock split to begin June 3 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews

May 28, 2025
pulisher
May 28, 2025

Oragenics (OGEN) Announces One-for-Thirty Reverse Stock Split | - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Oragenics announces reverse stock split to begin June 3 - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Oragenics Announces Reverse Stock Split to Boost Share Price - TipRanks

May 28, 2025
pulisher
May 28, 2025

Oragenics (OGEN) Announces One-for-Thirty Reverse Stock Split | OGEN Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Worksport Secures ISO 9001 Certification at U.S. Factory, Unlocking Revenue & OEM Growth Pathways - The Manila Times

May 28, 2025
pulisher
May 20, 2025

Oragenics Hosts Neurotrauma Medicine Webinar Presentation - TipRanks

May 20, 2025
pulisher
May 15, 2025

Oragenics (NYSE:OGEN) Earns Sell Rating from Analysts at StockNews.com - Defense World

May 15, 2025
pulisher
May 14, 2025

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

TotalEnergies sells 50% stake in Polish biogas company to HitecVision - Yahoo

May 14, 2025
pulisher
May 13, 2025

Oragenics (OGEN) Gains Approval for Phase II Trial of Neuroprote - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oragenics gains Australia’s nod for concussion therapy trial - Investing.com Australia

May 13, 2025
pulisher
May 13, 2025

Oragenics gains Australia’s nod for concussion therapy trial By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Oragenics, Inc. Announces Approval to Initiate Phase II Concussi - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia | OGEN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oragenics, Inc. to Host Management Update Webinar on May - GlobeNewswire

May 13, 2025
pulisher
May 12, 2025

Oragenics, Inc. to Host Management Update Webinar on May 20, 202 - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision | OGEN Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Oragenics, Inc. to Host Webinar on ONP-002 and Addressing Unmet Needs in Concussion Treatment - Nasdaq

May 12, 2025
pulisher
May 12, 2025

CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2025 Earnings Release Conference Call - The Manila Times

May 12, 2025
pulisher
May 10, 2025

Oragenics: Q1 Earnings Snapshot - New Haven Register

May 10, 2025

Finanzdaten der Oragenics Inc-Aktie (OGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Oragenics Inc-Aktie (OGEN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Odyssey Health, Inc.
10% Owner
Jun 17 '25
Sale
4.46
2,000
8,920
5,044
Odyssey Health, Inc.
10% Owner
Jun 16 '25
Sale
4.45
5,000
22,250
7,044
Odyssey Health, Inc.
10% Owner
Jun 13 '25
Sale
4.27
5,000
21,350
12,044
$21.00
price up icon 1.52%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):